> top > docs > PubMed:24719110 > annotations

PubMed:24719110 JSONTXT

Annnotations TAB JSON ListView MergeView

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-101 Sentence denotes Activation of spinal glucagon-like peptide-1 receptors specifically suppresses pain hypersensitivity.
TextSentencer_T2 102-286 Sentence denotes This study aims to identify the inhibitory role of the spinal glucagon like peptide-1 receptor (GLP-1R) signaling in pain hypersensitivity and its mechanism of action in rats and mice.
TextSentencer_T3 287-451 Sentence denotes First, GLP-1Rs were identified to be specifically expressed on microglial cells in the spinal dorsal horn, and profoundly upregulated after peripheral nerve injury.
TextSentencer_T4 452-692 Sentence denotes In addition, intrathecal GLP-1R agonists GLP-1(7-36) and exenatide potently alleviated formalin-, peripheral nerve injury-, bone cancer-, and diabetes-induced hypersensitivity states by 60-90%, without affecting acute nociceptive responses.
TextSentencer_T5 693-820 Sentence denotes The antihypersensitive effects of exenatide and GLP-1 were completely prevented by GLP-1R antagonism and GLP-1R gene knockdown.
TextSentencer_T6 821-920 Sentence denotes Furthermore, exenatide evoked β-endorphin release from both the spinal cord and cultured microglia.
TextSentencer_T7 921-1074 Sentence denotes Exenatide antiallodynia was completely prevented by the microglial inhibitor minocycline, β-endorphin antiserum, and opioid receptor antagonist naloxone.
TextSentencer_T8 1075-1219 Sentence denotes Our results illustrate a novel spinal dorsal horn microglial GLP-1R/β-endorphin inhibitory pathway in a variety of pain hypersensitivity states.
T1 0-101 Sentence denotes Activation of spinal glucagon-like peptide-1 receptors specifically suppresses pain hypersensitivity.
T2 102-286 Sentence denotes This study aims to identify the inhibitory role of the spinal glucagon like peptide-1 receptor (GLP-1R) signaling in pain hypersensitivity and its mechanism of action in rats and mice.
T3 287-451 Sentence denotes First, GLP-1Rs were identified to be specifically expressed on microglial cells in the spinal dorsal horn, and profoundly upregulated after peripheral nerve injury.
T4 452-692 Sentence denotes In addition, intrathecal GLP-1R agonists GLP-1(7-36) and exenatide potently alleviated formalin-, peripheral nerve injury-, bone cancer-, and diabetes-induced hypersensitivity states by 60-90%, without affecting acute nociceptive responses.
T5 693-820 Sentence denotes The antihypersensitive effects of exenatide and GLP-1 were completely prevented by GLP-1R antagonism and GLP-1R gene knockdown.
T6 821-920 Sentence denotes Furthermore, exenatide evoked β-endorphin release from both the spinal cord and cultured microglia.
T7 921-1074 Sentence denotes Exenatide antiallodynia was completely prevented by the microglial inhibitor minocycline, β-endorphin antiserum, and opioid receptor antagonist naloxone.
T8 1075-1219 Sentence denotes Our results illustrate a novel spinal dorsal horn microglial GLP-1R/β-endorphin inhibitory pathway in a variety of pain hypersensitivity states.

DisGeNET

Id Subject Object Predicate Lexical cue
T0 477-483 gene:2740 denotes GLP-1R
T1 594-602 disease:C0011847 denotes diabetes
T2 477-483 gene:2740 denotes GLP-1R
T3 594-602 disease:C0011849 denotes diabetes
T4 493-498 gene:100125288 denotes GLP-1
T5 594-602 disease:C0011847 denotes diabetes
T6 493-498 gene:100125288 denotes GLP-1
T7 594-602 disease:C0011849 denotes diabetes
T8 493-498 gene:79813 denotes GLP-1
T9 594-602 disease:C0011847 denotes diabetes
T10 493-498 gene:79813 denotes GLP-1
T11 594-602 disease:C0011849 denotes diabetes
T12 493-498 gene:2641 denotes GLP-1
T13 594-602 disease:C0011847 denotes diabetes
T14 493-498 gene:2641 denotes GLP-1
T15 594-602 disease:C0011849 denotes diabetes
R1 T0 T1 associated_with GLP-1R,diabetes
R2 T2 T3 associated_with GLP-1R,diabetes
R3 T4 T5 associated_with GLP-1,diabetes
R4 T6 T7 associated_with GLP-1,diabetes
R5 T8 T9 associated_with GLP-1,diabetes
R6 T10 T11 associated_with GLP-1,diabetes
R7 T12 T13 associated_with GLP-1,diabetes
R8 T14 T15 associated_with GLP-1,diabetes

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 219-223 HP_0012531 denotes pain
T2 581-587 HP_0002664 denotes cancer
T3 1190-1194 HP_0012531 denotes pain

Allie

Id Subject Object Predicate Lexical cue
SS1_24719110_1_0 164-196 expanded denotes glucagon like peptide-1 receptor
SS2_24719110_1_0 198-204 abbr denotes GLP-1R
AE1_24719110_1_0 SS1_24719110_1_0 SS2_24719110_1_0 abbreviatedTo glucagon like peptide-1 receptor,GLP-1R

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
24719110-0#21#44#gene2641 21-44 gene2641 denotes glucagon-like peptide-1
24719110-0#79#83#diseaseC0030193 79-83 diseaseC0030193 denotes pain
24719110-1#62#94#gene2740 164-196 gene2740 denotes glucagon like peptide-1 receptor
24719110-1#117#121#diseaseC0030193 219-223 diseaseC0030193 denotes pain
24719110-3#41#46#gene79813 493-498 gene79813 denotes GLP-1
24719110-3#41#46#gene2641 493-498 gene2641 denotes GLP-1
24719110-3#41#46#gene2740 493-498 gene2740 denotes GLP-1
24719110-3#41#46#gene100125288 493-498 gene100125288 denotes GLP-1
24719110-3#142#150#diseaseC0011847 594-602 diseaseC0011847 denotes diabetes
24719110-3#142#150#diseaseC0011849 594-602 diseaseC0011849 denotes diabetes
24719110-3#142#150#diseaseC0011847 594-602 diseaseC0011847 denotes diabetes
24719110-3#142#150#diseaseC0011849 594-602 diseaseC0011849 denotes diabetes
24719110-3#142#150#diseaseC0011847 594-602 diseaseC0011847 denotes diabetes
24719110-3#142#150#diseaseC0011849 594-602 diseaseC0011849 denotes diabetes
24719110-3#142#150#diseaseC0011847 594-602 diseaseC0011847 denotes diabetes
24719110-3#142#150#diseaseC0011849 594-602 diseaseC0011849 denotes diabetes
24719110-7#68#79#gene5443 1143-1154 gene5443 denotes β-endorphin
24719110-7#115#119#diseaseC0030193 1190-1194 diseaseC0030193 denotes pain
21#44#gene264179#83#diseaseC0030193 24719110-0#21#44#gene2641 24719110-0#79#83#diseaseC0030193 associated_with glucagon-like peptide-1,pain
62#94#gene2740117#121#diseaseC0030193 24719110-1#62#94#gene2740 24719110-1#117#121#diseaseC0030193 associated_with glucagon like peptide-1 receptor,pain
41#46#gene79813142#150#diseaseC0011847 24719110-3#41#46#gene79813 24719110-3#142#150#diseaseC0011847 associated_with GLP-1,diabetes
41#46#gene79813142#150#diseaseC0011849 24719110-3#41#46#gene79813 24719110-3#142#150#diseaseC0011849 associated_with GLP-1,diabetes
41#46#gene79813142#150#diseaseC0011847 24719110-3#41#46#gene79813 24719110-3#142#150#diseaseC0011847 associated_with GLP-1,diabetes
41#46#gene79813142#150#diseaseC0011849 24719110-3#41#46#gene79813 24719110-3#142#150#diseaseC0011849 associated_with GLP-1,diabetes
41#46#gene79813142#150#diseaseC0011847 24719110-3#41#46#gene79813 24719110-3#142#150#diseaseC0011847 associated_with GLP-1,diabetes
41#46#gene79813142#150#diseaseC0011849 24719110-3#41#46#gene79813 24719110-3#142#150#diseaseC0011849 associated_with GLP-1,diabetes
41#46#gene79813142#150#diseaseC0011847 24719110-3#41#46#gene79813 24719110-3#142#150#diseaseC0011847 associated_with GLP-1,diabetes
41#46#gene79813142#150#diseaseC0011849 24719110-3#41#46#gene79813 24719110-3#142#150#diseaseC0011849 associated_with GLP-1,diabetes
41#46#gene2641142#150#diseaseC0011847 24719110-3#41#46#gene2641 24719110-3#142#150#diseaseC0011847 associated_with GLP-1,diabetes
41#46#gene2641142#150#diseaseC0011849 24719110-3#41#46#gene2641 24719110-3#142#150#diseaseC0011849 associated_with GLP-1,diabetes
41#46#gene2641142#150#diseaseC0011847 24719110-3#41#46#gene2641 24719110-3#142#150#diseaseC0011847 associated_with GLP-1,diabetes
41#46#gene2641142#150#diseaseC0011849 24719110-3#41#46#gene2641 24719110-3#142#150#diseaseC0011849 associated_with GLP-1,diabetes
41#46#gene2641142#150#diseaseC0011847 24719110-3#41#46#gene2641 24719110-3#142#150#diseaseC0011847 associated_with GLP-1,diabetes
41#46#gene2641142#150#diseaseC0011849 24719110-3#41#46#gene2641 24719110-3#142#150#diseaseC0011849 associated_with GLP-1,diabetes
41#46#gene2641142#150#diseaseC0011847 24719110-3#41#46#gene2641 24719110-3#142#150#diseaseC0011847 associated_with GLP-1,diabetes
41#46#gene2641142#150#diseaseC0011849 24719110-3#41#46#gene2641 24719110-3#142#150#diseaseC0011849 associated_with GLP-1,diabetes
41#46#gene2740142#150#diseaseC0011847 24719110-3#41#46#gene2740 24719110-3#142#150#diseaseC0011847 associated_with GLP-1,diabetes
41#46#gene2740142#150#diseaseC0011849 24719110-3#41#46#gene2740 24719110-3#142#150#diseaseC0011849 associated_with GLP-1,diabetes
41#46#gene2740142#150#diseaseC0011847 24719110-3#41#46#gene2740 24719110-3#142#150#diseaseC0011847 associated_with GLP-1,diabetes
41#46#gene2740142#150#diseaseC0011849 24719110-3#41#46#gene2740 24719110-3#142#150#diseaseC0011849 associated_with GLP-1,diabetes
41#46#gene2740142#150#diseaseC0011847 24719110-3#41#46#gene2740 24719110-3#142#150#diseaseC0011847 associated_with GLP-1,diabetes
41#46#gene2740142#150#diseaseC0011849 24719110-3#41#46#gene2740 24719110-3#142#150#diseaseC0011849 associated_with GLP-1,diabetes
41#46#gene2740142#150#diseaseC0011847 24719110-3#41#46#gene2740 24719110-3#142#150#diseaseC0011847 associated_with GLP-1,diabetes
41#46#gene2740142#150#diseaseC0011849 24719110-3#41#46#gene2740 24719110-3#142#150#diseaseC0011849 associated_with GLP-1,diabetes
41#46#gene100125288142#150#diseaseC0011847 24719110-3#41#46#gene100125288 24719110-3#142#150#diseaseC0011847 associated_with GLP-1,diabetes
41#46#gene100125288142#150#diseaseC0011849 24719110-3#41#46#gene100125288 24719110-3#142#150#diseaseC0011849 associated_with GLP-1,diabetes
41#46#gene100125288142#150#diseaseC0011847 24719110-3#41#46#gene100125288 24719110-3#142#150#diseaseC0011847 associated_with GLP-1,diabetes
41#46#gene100125288142#150#diseaseC0011849 24719110-3#41#46#gene100125288 24719110-3#142#150#diseaseC0011849 associated_with GLP-1,diabetes
41#46#gene100125288142#150#diseaseC0011847 24719110-3#41#46#gene100125288 24719110-3#142#150#diseaseC0011847 associated_with GLP-1,diabetes
41#46#gene100125288142#150#diseaseC0011849 24719110-3#41#46#gene100125288 24719110-3#142#150#diseaseC0011849 associated_with GLP-1,diabetes
41#46#gene100125288142#150#diseaseC0011847 24719110-3#41#46#gene100125288 24719110-3#142#150#diseaseC0011847 associated_with GLP-1,diabetes
41#46#gene100125288142#150#diseaseC0011849 24719110-3#41#46#gene100125288 24719110-3#142#150#diseaseC0011849 associated_with GLP-1,diabetes
68#79#gene5443115#119#diseaseC0030193 24719110-7#68#79#gene5443 24719110-7#115#119#diseaseC0030193 associated_with β-endorphin,pain

DisGeNet-2017-sample

Id Subject Object Predicate Lexical cue
T2712 493-498 gene:79813 denotes GLP-1
T2713 594-602 disease:C0011847 denotes diabetes
R1 T2712 T2713 associated_with GLP-1,diabetes
R2 T2712 T2713 associated_with GLP-1,diabetes
R3 T2712 T2713 associated_with GLP-1,diabetes
R4 T2712 T2713 associated_with GLP-1,diabetes
R5 T2712 T2713 associated_with GLP-1,diabetes
R6 T2712 T2713 associated_with GLP-1,diabetes
R7 T2712 T2713 associated_with GLP-1,diabetes
R8 T2712 T2713 associated_with GLP-1,diabetes

UBERON-AE

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 388-392 http://purl.obolibrary.org/obo/UBERON_0006967 denotes horn
PD-UBERON-AE-B_T2 1120-1124 http://purl.obolibrary.org/obo/UBERON_0006967 denotes horn
PD-UBERON-AE-B_T3 438-443 http://purl.obolibrary.org/obo/UBERON_0001021 denotes nerve
PD-UBERON-AE-B_T4 561-566 http://purl.obolibrary.org/obo/UBERON_0001021 denotes nerve
PD-UBERON-AE-B_T5 885-896 http://purl.obolibrary.org/obo/UBERON_0002240 denotes spinal cord

performance-test

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 438-443 http://purl.obolibrary.org/obo/UBERON_0001021 denotes nerve
PD-UBERON-AE-B_T2 561-566 http://purl.obolibrary.org/obo/UBERON_0001021 denotes nerve
PD-UBERON-AE-B_T3 388-392 http://purl.obolibrary.org/obo/UBERON_0006967 denotes horn
PD-UBERON-AE-B_T4 1120-1124 http://purl.obolibrary.org/obo/UBERON_0006967 denotes horn
PD-UBERON-AE-B_T5 885-896 http://purl.obolibrary.org/obo/UBERON_0002240 denotes spinal cord